Abacavir, Didanosine: myocardial infarction.
D044966:Anti-Retroviral Agents / Q000009:adverse effects; D001315:Australia; D015331:Cohort Studies; D016049:Didanosine / Q000009:adverse effects*; D015224:Dideoxynucleosides / Q000009:adverse effects*; D005060:Europe; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced*; D012306:Risk; D014481:United States
D044966:Anti-Retroviral Agents; D015224:Dideoxynucleosides; D016049:Didanosine